Tuesday, 13 December 2022

Over £175 million for cutting-edge genomics research

Over £175 million for cutting-edge genomics research Patients with cancer and children born with treatable rare genetic diseases are set to benefit from earlier diagnosis and faster access to treatment, following a £175 million boost to cutting-edge genomics research announced by the Health and Social Care Secretary.

The funding will enable research which could deliver world-leading genomic healthcare to patients, which involves the study of people’s DNA. The boost is part of a new three-year plan to develop, evaluate and roll out new technologies across the health and care system and life sciences sector, bolstering the UK’s position as a life sciences superpower. Department of Health and Social Care

See also:

No comments:

Post a Comment